Cell Cycle Oscillating Degron Tags for rAAV Stable Cell Line Development

This technology offers a transformative solution for gene therapy manufacturing. It provides a cost-effective and reliable method to enhance viral vector production, ensuring higher yields and quality.

Technology

Recombinant adeno-associated virus (rAAV) vectors are a cornerstone of modern gene therapy. Stable producer cell lines offer a promising solution in the field by providing a consistent and scalable platform. The expression of replication (Rep) proteins, which are crucial for the replication and packaging of transgene DNA into viral capsids, poses a significant challenge. In stable cell lines, continuous expression of these proteins can lead to cell cycle arrest and cell death, severely limiting the productivity and viability of the cell lines. Current strategies to mitigate these effects are complex and inefficient. UD Researchers have sought to address this problem, their invention introduces the use of cell cycle oscillating degron tags to modulate the expression of Rep proteins in rAAV-producing stable cell lines. By employing these degron tags, the Rep proteins are degraded in an oscillating manner, allowing for controlled expression that prevents cell cycle arrest and enhances viral vector production. This approach maintains sufficient levels of Rep proteins for effective rAAV production while mitigating their toxic effects on the producer cells. This technology offers a transformative solution for gene therapy manufacturing. It provides a cost-effective and reliable method to enhance viral vector production, ensuring higher yields and quality. This innovation not only addresses critical production bottlenecks but also positions pharmaceutical companies to meet the growing demand for gene therapies with improved scalability and reduced operational risks.

Benefits

  • Reduction in production costs through stable cell line development
  • Improved consistency and efficiency in rAAV production
  • Mitigation of toxic effects associated with Rep protein expression in producer cells

Applications

  • Development of stable cell lines for pharmaceutical companies focused on viral vector production for gene therapies
  • Enhancement of rAAV production processes in biopharmaceutical manufacturing